Morgan Lewis partner Rebecca Dandeker was quoted in an HBW Insight article about the need for the US Food and Drug Administration (FDA) to provide guidance regarding over-the-counter (OTC) monographs. “The standard for establishing the safety and effectiveness of this new ingredient or this new dosage form remains the same. . . . But what is more complex is that FDA now will be reviewing and potentially passing judgement about each and every one of those [generally regarded as safe and effective] data pieces,” said Rebecca in the article.